Back to Screener

Healthcare

Regeneron Pharmaceuticals, Inc.(REGN)

Live Price

Offline

$609.94

+0.33% today

1Y Change

+20.09%

Window

Jun 20, 2025 โ†’ Jun 12, 2026

Market Cap
$72.26B
Revenue Growth
+1.0%
EPS Growth
+5.3%
Dividend Yield
0.5%

Coverage: 246 bars ยท Jun 20, 2025 โ†’ Jun 12, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

Regeneron Pharmaceuticals, Inc. (REGN) is a Healthcare stock with a market cap of $72.26B and listed on NASDAQ. The stock last traded around $609.94 and up 20.1% across the available one-year price window (Jun 20, 2025 โ†’ Jun 12, 2026). Baseline metrics include revenue growth of +1.0%, EPS growth of +5.3%, a dividend yield of 0.5%. What stands out right now is revenue +1.0%, EPS +5.3%, free cash flow +11.3% with operating margin 24.3% and ROIC 8.5%. The dividend is present but secondary, with a yield around 0.5%. Valuation is more restrained than many high-expectation growth names at P/E 16.5 and price/sales 4.8. Stock Foundry combines REGN price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.

Benchmark Comparison

Normalized Performance vs SPY

Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.

1Y shared range

REGN

โ€”

Normalized return

SPY

โ€”

S&P 500

Excess Return

โ€”

Relative to SPY

REGN Max Drawdown

-26.05%

Trailing 1Y

SPY Max Drawdown

โ€”

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for REGN and SPY.

Calendar-year return history is still loading or unavailable.

Earnings Reports

๐Ÿ“… Last reportedApr 29, 2026
PeriodB/MEPSEPS ฮ”RevenueRev ฮ”Report
โ€”
Apr 29, 26
โ€”
Est 9.10
โ€”
โ€”
Est 3447921.0B
โ€”
Apr 29
โ€”
Jan 30, 26
โœ“
11.44
Est 10.74
+6.5%
3884300.0B
Est 3810747.0B
+1.9%
Jan 30
โ€”
Oct 28, 25
โœ“
11.83
Est 9.65
+22.6%
3754300.0B
Est 3592157.3B
+4.5%
Oct 28
โ€”
Aug 1, 25
โœ“
12.89
Est 8.43
+52.9%
3675600.0B
Est 3288131.1B
+11.8%
Aug 1
โ€”
Apr 29, 25
โœ—
8.22
Est 8.62
-4.6%
3028700.0B
Est 3248029.0B
-6.8%
Apr 29
โ€”
Feb 4, 25
โœ“
12.07
Est 11.21
+7.7%
3789200.0B
Est 3742241.7B
+1.3%
Feb 4
โ€”
Oct 31, 24
โœ“
12.46
Est 11.69
+6.6%
3720700.0B
Est 3674802.6B
+1.3%
Oct 31
โ€”
Aug 1, 24
โœ“
11.56
Est 10.61
+8.9%
3547100.0B
Est 3383512.9B
+4.8%
Aug 1
โ€”
May 2, 24
โœ—
9.55
Est 10.17
-6.1%
3145000.0B
Est 3225221.4B
-2.5%
May 2
โ€”
Feb 2, 24
โœ“
11.86
Est 10.73
+10.5%
3434300.0B
Est 3294355.8B
+4.3%
Feb 2
โ€”
Nov 2, 23
โœ“
11.59
Est 10.72
+8.1%
3362700.0B
Est 3221000.0B
+4.4%
Nov 2
โ€”
Aug 3, 23
โœ“
10.24
Est 9.84
+4.1%
3158100.0B
Est 3016800.0B
+4.7%
Aug 3
โ€”
May 4, 23
โœ“
10.09
Est 9.25
+9.1%
3162100.0B
Est 3000380.0B
+5.4%
May 4
โ€”
Feb 3, 23
โœ“
12.56
Est 10.03
+25.2%
3414400.0B
Est 3124683.9B
+9.3%
Feb 3
โ€”
Nov 3, 22
โœ“
11.14
Est 9.48
+17.5%
2936200.0B
Est 2915357.7B
+0.7%
Nov 3
โ€”
Aug 3, 22
โœ“
9.77
Est 8.53
+14.5%
2857200.0B
Est 2794409.7B
+2.3%
Aug 3
โ€”
May 4, 22
โœ—
8.93
Est 9.74
-8.3%
2965100.0B
Est 2690104.2B
+10.2%
May 4
โ€”
Feb 4, 22
โœ“
21.32
Est 18.35
+16.2%
4951700.0B
Est 4562522.1B
+8.5%
Feb 4
โ€”
Nov 4, 21
โœ“
14.37
Est 10.10
+42.3%
3452800.0B
Est 2686080.0B
+28.5%
Nov 4
โ€”
Aug 5, 21
โœ“
25.80
Est 17.53
+47.2%
5138500.0B
Est 3916760.0B
+31.2%
Aug 5
No upcoming earnings in the next 90 days

Next Step

Connect reports to catalysts

Earnings pages get much more useful when they are tied back to upcoming dates, expectations, and peer setups.

Read the earnings calendar guideOpen the calendar screener